PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

AptarGroup, Inc.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from AptarGroup, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Steadiness Ratio: Sales and profit both grew in each of the last 3 years. Steadier than 96% of Healthcare companies in United States.

Where $100 of sales goes

$86Operating costs$1.4Interest$10Net profit$3.2Paid as dividends

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

$170

Over the last 3 years, every $100 of reported profit came with $170 of operating cash.

Higher than 64% of Healthcare companies in United States.

Self-Funding Ratio

2.0×

Over the last 3 years its own operating cash covered its investment spending (capex) 2.0 times.

Higher than 74% of Healthcare companies in United States.

Cash Locked Ratio

$27

For every $100 of sales, $27 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $25 tied up three years earlier.

More money tied up than 57% of Healthcare companies in United States.

Growth quality

Steadiness Ratio

3/3 · 3/3

Sales and profit both grew in each of the last 3 years.

Steadier than 96% of Healthcare companies in United States.

Growth Efficiency Ratio

$34

Sales grew 14% in 3 years; of every extra $100 of sales, $34 became extra profit.

Higher than 60% of Healthcare companies in United States.

Asset Productivity Ratio

+14% / +25%

In 3 years sales changed by +14% while total assets changed by +25%. Assets grew faster than sales.

Balance-sheet strength

Debt Due Cover Ratio

1.7×

Debt due within a year is covered 1.7 times by its yearly operating cash.

Higher than 73% of Healthcare companies in United States.

Cash Cushion Ratio

−14%

Debt, after subtracting cash, equals 14% of its market value (net debt).

Lower than 81% of Healthcare companies in United States.

Tangible Assets Ratio

75%

Of every $100 the company owns, $75 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 58% of Healthcare companies in United States.

Tangible Net Worth Ratio

50%

Of every $100 of net worth, $50 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

Less tangible than 53% of Healthcare companies in United States.

Shareholders

Shareholder Slice Ratio

−2%

Share count fell 2% in 3 years (buybacks), so each share's slice of the company became larger. Dividends paid equalled 32% of profit over the same period.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (14)

AptarGroup, Inc. owes $0.48 for every $1 it owns. Net profit rose 5% in the year to Dec 2025, and grew 18% a year on average over 3 years.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

22.8

Investors pay $22.8 for every $1 of AptarGroup, Inc.'s yearly profit, lower than 57% of Healthcare companies in United States.

P/B ratio

3.06

The share price is 3.06 times AptarGroup, Inc.'s book value per share, higher than 57% of Healthcare companies in United States.

Market cap

$8.0 B

The total market value of all of AptarGroup, Inc.'s shares at today's price (share price × number of shares), larger than 88% of Healthcare companies in United States. PosiCap size class: Meso Cap.

Net worth (book value)

$2.6 B

What AptarGroup, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).

Book value per share

$41.36

Net worth divided by the number of shares. The share price of $126.55 is 3.1 times this, which is the P/B above.

Return on equity (ROE)

13.5%

AptarGroup, Inc. earned 13.5% on its shareholders' money over the last year, higher than 86% of Healthcare companies in United States.

Owes vs Owns

0.48×

AptarGroup, Inc. owes $0.48 for every $1 it owns (low), higher than 54% of Healthcare companies in United States.

Dividend yield

1.50%

AptarGroup, Inc. pays 1.50% of its share price as dividends a year, higher than 64% of dividend-paying Healthcare companies in United States.

Revenue growth

+5%

Revenue rose 5% in the year to Dec 2025, and grew 4% a year on average over 3 years.

Profit growth

+5%

Net profit rose 5% in the year to Dec 2025, and grew 18% a year on average over 3 years.

Profit margin

10.4%

AptarGroup, Inc. keeps $10 of every $100 of revenue as net profit.

Cash quality

1.5×

Cash from AptarGroup, Inc.'s business was 1.5× its reported profit in the year to Dec 2025 — its profit turned into cash.

Interest cover

9.7×

AptarGroup, Inc.'s operating profit covered its interest costs 9.7 times in the year to Dec 2025.

Cash vs debt

Net debt

AptarGroup, Inc. had $1.1 B more debt than cash (net debt) at Dec 2025.

Questions

What is AptarGroup, Inc.'s P/E ratio?

Investors pay $22.8 for every $1 of AptarGroup, Inc.'s yearly profit, lower than 57% of Healthcare companies in United States.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For AptarGroup, Inc.: $8.0 B ÷ $2.6 B (31 Mar 2026) = 3.1.

What is AptarGroup, Inc.'s return on equity?

AptarGroup, Inc. earned 13.5% on its shareholders' money over the last year, higher than 86% of Healthcare companies in United States.

How much does AptarGroup, Inc. owe compared with what it owns?

AptarGroup, Inc. owes $0.48 for every $1 it owns (low), higher than 54% of Healthcare companies in United States.

Does AptarGroup, Inc. pay a dividend?

Yes. AptarGroup, Inc. pays 1.50% of its share price as dividends a year, higher than 64% of dividend-paying Healthcare companies in United States.

Is AptarGroup, Inc.'s revenue growing?

Revenue rose 5% in the year to Dec 2025, and grew 4% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.